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An intriguing property of human transferrin,
a normally occurring beta globulin, is its ability
to inhibit the growth of various organisms
pathogenic to man (1, 2). This non-specific
effect is most likely related to its affinity for iron
and the case with which, by alteration of physio-
logic conditions, iron binding can be reversed.
Whereas the degree of bacteriostasis of Staph y-
lococcus aureus grown in human serum can be
inversely correlated with the percentage of iron
saturation, other organisms (e.g. Staph ylococcus
albus) show no growth unless iron is provided
in excess of the amount required to saturate
transferrin. Serum from agammaglobulinemic
patients has both a higher level of heat stable
bacteriostatic activity against Bacillus subtilis
and an increased unsaturated iron binding
capacity (UIBC) compared to normal serum
(3). This finding suggested that the increased
levels of unsaturated transferrin may represent
a compensatory defense mechanism in the
agammaglobulinemic host. The addition of puri-
fied human transferrin to tissue culture media
has also been shown to cause marked suppres-
sion of the cytopathogenic effect of several types
of virus (4).
In vitro inhibition of the growth of fungi by
human serum has been observed by many in-
vestigators. Szilagyi, Reiss and Smith have dem-
onstrated inhibition of growth of Cry ptococcus
neoformans by human serum and reversal of
this inhibition with the addition of ferrous am-
monium sulfate; however, when individual pro-
tein fractions replaced whole serum in the assay,
much of the inhibitory activity was in the alpha2
and gamma globulin fractions (5). This would
imply that growth of Cry ptococcus in human
serum is not only contingent upon the presence
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of available iron or the saturation of transfer-
rin but that the growth rate of the organism
in this system is also affected by another globu-
lin fraction.
The transferrin-iron complex has also been im-
plicated as a factor responsible for serum inhibi-
tion of candidal growth. Caroline and coworkers
(6) demonstrated that normal inhibitory activ-
ity was abolished by the addition of ferrous iron
in excess of that required to saturate the UIBC.
The addition of graded amounts of iron to un-
dilated serum reversed inhibition of candidal
growth only when 100% saturation of trans-
ferrin was reached; iron in excess of 100%
saturation failed to further stimulate growth.
Saturation of transferrin has also been shown
to increase the percentage of germ tubes formed
by Candida albicans incubated with serum at
37° C. Moreover, removal of bound iron with a
chelating agent, desferrioxamine B, will reverse
this phenomenon. The authors suggested that
added iron blocked an inbibitory factor (unsatu-
rated transferrin) rather than directly enhancing
growth (i.e. germ tube formation) (7).
A human serum factor which inhibits in vitro
growth of C. albicans at room temperature has
been described by Roth and coworkers (5, 9).
Under these laboratory conditions Candida al-
bicans multiplies by blastospore formation rather
than by formation of mycclial elements. This in-
hibitory factor is absent from cord serum and
that of young infants (5, 10), and from scra of
most individuals with acute leukemia, multiple
myeloma, Hodgkin's disease (9) and sickle
cell anemia (10). Lack of inhibitory capacity
in these patients as well as differences in
physical characteristics distinguish Roth's fac-
tor from the germ tube factor, and from the
killing substance of Louria and Brayton (11).
Although the serum factors affecting candidal
growth appear to differ in these several respects,
some of the characteristics of both the germ
tube factor and the killing factor have implicated
transferrin as the active substance. The satura-
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tion state of transferrin has been shown to di-
rectly affect germ tube formation (7) and the
killing factor activity (11) has been localized to
the alpha and beta serum globulin fractions. The
present study is an attempt to relate serum in-
hibition of eandidal growth at room temperature
(Roth's factor) to the iron-transferrin system.
Such a connection might provide further evi-
dence that transferrin functions not as only a
carrier substance in iron transport but as a non-
specific resistance factor as well.
MATERIAL5 AND METHODS
Yeast strain. A strain of Candida albicans iso-
lated from a patient with vaginitis was maintained
on Saboraud's media and subeultured monthly.
This organism was the same as that characterized
and used previously (10).
Scm. The serum was collected aseptically in
iron-free tubes with 19 gauge disposable needles
and plastic syringes. After clot formation occurred,
it was separated by low speed eentrifugation and
stored at —20° C in iron-free vials. Serum pooled
from four healthy individuals with normal in-
hibitory activity against C. albicans was used as
the control stock preparation.
Medium. The medium used for preparation of
the inoculum and for tile assay tubes was com-
posed of 5% peptone (Difeo), 0.1% yeast extract
(Difeo), 0.2% dextrose and 0.3% NaC1. A single
lot of media was used throughout the experiment;
the iron content was 48 pg/100 ml and the pH
was 6.6. Thus the final iron concentration of the
assay tube was known to be 0.24 pg/mi.
Trans ferrin. Human pooled plasma transferrin,
B grade, 95% pure (Cal. Biochem. Pentex) was
dissolved in sterile, iron-free physiologic saline
with 0.2% dextrose or in an iron-free phosphate
buffer pH 6.5 or 7.5.
Iron and magnesium. Iron was added to the
assay tubes in 5- or 10-pg quantities as ferrous
ammonium sulfate (Fe504 (NH4)2SOc6H2O) or
ferrie chloride (FeCls6H2O) dissolved in sterile
physiologic saline with 0.2% dextrose. Magnesium
was added as magnesium chloride (MgCI2 .6H20)
8 pg/ml in sterile physiologic saline with 02%
dextrose.
Serum iron and unsaturated iran-binding ca-
pacity (UIBC). Calorimetric determinations were
performed by the method of Schade et a!. (12).
The total iron binding capacity (TIBC) and per-
cent saturation of transfarrin were calculated from
these values.
Serum assay. The C. albicans inoculum was
prepared from a broth culture which had been
incubated on a gyrotary shaker at 200 r.p.m. for 20
hours at roam temperature. The harvested cells
were spun, washed and diluted to 250,000—350,000/
ml in sterile iron-free physiologic saline. The assay
tubes contained 1.0 ml of broth, 0.5 ml of physio-
logic saline with 0.2% dextrose, 0.4 ml of serum
and 0.1 ml of inoculum. The amount of iron endog-
enous to the broth was insufficient to significantly
saturate the transferrin present in the test serum.
In these experiments in which the serum was
omitted an equal volume of saline or phosphate
buffer was used.
The assay tubes were incubated on a gyrotary
shaker at 170 r.p.m. for 24 hours at room tempera-
ture. Growth of the organisms was determined by
optical density and percent transmission readings
in a Coleman Junior Spectrophotometer at 6SOp.
The results were expressed at AT (AT initial
percent transmission — percent transmission at 24
hours). A large AT indicates lack of inhibition of
candidal growth; a small AT, good inhibition or
minimal candidal growth. The methods have been
described in detail previously (10).
REsULTs
Effect of the addition of transferrin to assay
tubes without serum. Four-tenths ml of pooled
human transferrin dissolved in phosphate buffer
in concentrations of 2.5 mg/mI, 5 mg/ml, 10
mg/ml and 15 mg/ml was used in place of the
0.4 ml of serum in the assay tubes. All of the
concentrations were run at both pH 6.5 and 7.5.
The concentration of transferrin in normal hu-
man serum is approximately 250 mg%, but
larger amounts of the exogenous transferrin were
used in the assay to allow for possible partial
inactivation of the preparation. Candidal growth
was not inhibited (Table I) and equalled that of
the control tube (AT 75) in all of the assay
tubes (AT 68—73).
Effect of the addition of transferrin to assay
tubes with serum. Five-tenths ml of physiologic
saline and 0.2% dextrose containing transferrin
in a concentration of 8 mg/mi was added to sera
which were known not to inhibit candidal growth
under standard assay conditions. This group in-
cluded five card sera, one sample each from an
infant three weeks of age, a patient with leu-
kemia, another with hypoplastie anemia, and
four sera from patients with hemoglobinopathies
(three SS, one SC). Whereas the addition of 4
mg of transferrin to cord sera did not appreci-
ably affect eandidal growth, the sera from all of
the remaining patients showed normal inhibitory
activity when transferrin was added in the
above amount (Table II).
Effect of the addition of iron to a normally
inhibiting serum. Ferrous and ferrie iron dis-
solved in dextrose-saline in amounts of 5 and
10 g were added to assay tubes containing the
pooled stock serum (activity = AT 5). The
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Specimen
Blank
Control (without serum or trans-
ferrin)
Buffer pH 6.5 without transferrin
Buffer pH 7.5 without transferrin
Buffer pH 6.5 and 2.5 mg/mi trans-
ferrin
Buffer pH 7.5 and 2.5 mg/mI trans-
ferrin
Buffer pH 6.5 and 5 mg/mi trans-
ferrin
Buffer pH 7.5 and 5 mg/ml trans-
ferrin
Buffer pH 6.5 and 10mg/mi trans-
ferrin
Buffer pH 7.5 and 10 mg/ml trans-
ferrin
Buffer pH 7.5 and 15mg/mi trans-
ferrin
Blank
Control
Control
Cord 1
Cord 2
Cord ,3
Cord 4
Cord 5
mlant, 3 weeks
Acute leukemia
Hypopiastic anemia
SS hemoglobinopathy , 1
SS hemoglobinopathy 2
SS hemoglobinopathy 3
SC hemoglobinopathy
0
5
72
68
71
75
67
66
67
64
74
68
69
65
68
0
75
73
69
70
68
69
73
70
72
TABLE I
Addition of transferrin in phosphate buffer
assay tubes without serum*
TABLE III
Addition of iron to assay lubes with serum*
Specimen XT
Blank 0
Control (without serum) 72
Control (without serum) +10 73Fe+
Pooled serum without iron 5
Pooled serum at 60% saturation 21(Fe)
Pooled serum at 80% saturation 58(Fe)
Pooled serum at 100% saturation 73(Fej
Pooled serum at 120% saturation 72(Fe)
Pooled serum + 5 ig Fe 72
Pooled serum + 5 eg Fe 69
Pooled serum + 10 zg 72
Pooled serum + 10 g Fe 70
* 0.4 ml phosphate buffer with transferrin re-
placed the serum in the total 2-ml volume.
TABLE II
Addition of transferrin to assay tubes with serurn*
Specimen
T without
transferrin
T with
transferrin
(pooled stock serum)
(without serum)
65 * Iron added as FeSO4 (NH4)2S04.6H202 or
FeC136H2O.
growth; the large excess provided in those tubes
with 10 pg of iron did not, however, stimulate
more growth than smaller amounts (Table III).
Iron as ferrous ammonium sulfate was added in
graded amounts to the same control serum.
There was no effect on the inhibitory activity
until a saturation of 60% was reached. At this
level of saturation the iT dropped from 5 to 21;
a further drop to T 58 occurred at 80% satu-
ration. At 100% saturation the T was 73 and
78 persisted at saturation levels up to 150%.
61 Effect of the addition of magnesium to nor-
72 mally inhibiting serum. The addition of mag-
67 nesium to the pooled stock serum in amounts of
64 2 and 4 pg per tube did not affect candidal
15 growth (ST, 3,2).
22
Serum iron and UIBC. Serum iron, UIBC,
6 TIBC and percent saturation were determined
27 for 59 sera; inhibitory activity has been previ-
ously reported for many of the samples (10).
ii Serum obtained subsequently has been tested
for inhibitory capacity under the standard as-
say conditions. No significant correlation was
found between the degree of inhibitory activity
(zT) and the serum iron or TIBC. The rela-
tionship of the T to the TIIBC values is shown
in Figure 1. All of the sera which had a normal
inhibitory capacity (T 1—23) had a TIIBC of
200 tg% or greater with a range of 200—492
* Transferrin added in a concentration of 8
mg/ml as 4 mg dissolved in 0.5 ml of physiologic
saline and 0.2% dextrose.
UIBC of this serum was 289 tg%; therefore,
both amounts provided iron in excess of the
binding capacity. Addition of either ionic form
completely reversed inhibition of candidal
FIG. 1. Inhibitory
g%. One sample was from a patient with sickle
cell anemia, the only patient assayed so far
with SS hemoglobin and a normal capacity to
inhibit eandidal growth. The remainder were
from normal children aged 3 months to 5 years
seen for superficial bacterial pyoderma. The non-
inhibiting group consists of specimens from pa-
tients with bemoglobinopathies, (nine SS, one
SC), blood dyscrasias (three leukemia, one con-
genital hereditary spherocytosis), and cord sera
(13 samples). The range of values for the non-
inhibiting sera was 13—234 tg%; six of the 27
had a TJIBC greater than 200 zg% and none
were greater than 240 Lg%. The difference be-
tween the two groups of TIIBC values (the nor-
mally inhibiting and the non-inhibiting sera)
was significant at p <.0001. The degree of trans-
ferrin saturation also correlated with lack of in-
hibition. However, the number of sera of suf-
ficient volume to allow determination of %
saturation was too small for statistical evalua-
tion.
COMMENT
It has been previously demonstrated that in
vitro growth of Candida albican.s in human se-
rum at 37° C is related to the degree of satura-
tion of serum transferrin (6, 7). The results of
this study show that in human serum at 25° C
the growth of C. albicans is also closely related
• Normal Children
A Cord
• Blood Dyscrasia or
Hemoglobinopathy
to the saturation state of transferrin and that
serum inhibitory activity is specifically corre-
lated with the UIBC.
In normal adults and children the TIBC
(TJIBC and serum iron) is approximately 350
g% with a range of 250—400 xg%; serum iron
levels range from 70—170 pg% (13, 14). Whereas
most of the normally inhibiting sera fall within
the range of normal measurement for IJIBC,
a few have excessively high values. The patient
with the highest TJIBC, 491 pg%, had known
iron deficiency anemia, a disease state in which
the serum iron is low and the TIBC high
(up to 600 g%) (14). Since these patients were
drawn from an indigent population it is prob-
able that iron deficiency anemia accounted for
the several other values in the higher than nor-
mal range; low serum iron levels for these in-
dividuals support this postulate.
That the iron binding capacity of cord serum
is almost completely saturated (60—70%) has
been amply documented (15, 16). Within hours
after birth there is a drop in serum iron and a
concomitant drop in the iron-binding capacity
thus maintaining a high percent saturation
(15). During the first postnatal week both se-
rum iron and iron-binding capacity rise to ap-
proximately 150 g% and 250 g%, resulting in
a TJIBC of about 100 g% (17). The UIBCs
of the cord sera in this study show good agree-
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ment with established values. Twelve of the 13
sera had UIECs below 160 tg%; the thirteenth
was 203 /Lg%. Lack of inhibition and a low
UIIBC were closely correlated for this group of
sera. Likewise the low UIBC in early infancy
may account for the lack of inhibitory activity
previously demonstrated in this age group (10).
The relationship of iron and transferrin in hu-
man serum is such that when the iron is low,
the TIBC and the UIBC are high; conversely,
when the serum iron is high, the TIBC and
UIBC are low. Exceptions to this occur in the
anemias of infection, inflammation and malig-
nancy in which both the serum iron and the
TIEC are reduced. High serum iron levels are
found in conditions of increased iron storage
(liemachromatosis), decreased crythropoiesis
(aplastic or hypoplastic anemia, acute leu-
kemia), or increased iron release to the plasma
relative to the amount being utilized for red cell
production (hemolytic anemias). Since the
TIBC remains relatively constant, presumably
the UIBC is decreased. This mechanism prob-
ably accounts for the low UIBCs seen in patients
with hematologic disorders who lack inhibitory
activity.
The addition of iron as either ferrous or ferric
ion abolishes the inhibitory activity of human
serum in this system. Partial loss of inhibition
becomes apparent only when the UBC is satu-
rated to a level of 80% and complete loss of in-
hibition occurs when 100% saturation is reached.
The addition of iron in excess of this amount
fails to stimulate further growth of C. albicons.
These data suggest that the addition of iron may
block an inhibitory effect of transferrin rather
than directly affecting growth. Caroline and co-
workers (6) added graded amounts of iron to a
serum with a known high IJIBC and demon-
strated the same phenomenon in a 37° C system.
There was little change in candidal growth until
100% saturation was reached. The use of a
"low"-iron conalbumin medium with graded
amounts of iron added also produced the same
effect. Limited growth was attributed to iron
deprivation, and increased growth noted at the
level of 100% saturation, to provision of iron
necessary for metabolism. Hosvcver, it is con-
ceivable that conalbumin and transfcrrin both
act to inhibit canidal growth in a non-specific
way; this effect may be eliminated when the pro-
tein is iron-saturated. When increasing amounts
of radioactive iron were added to a 30% satu-
rated serum an increasing amount of candidal
growth and incorporation of radioactive iron
was noted at 50, 90 and 120% levels of satura-
tion (6). However, the measurement of radio-
active iron uptake was done on the total cell
mass and may reflect an increase in cell mass
rather than an actual increase in iron uptake per
cell.
If unsaturated transferrin were the inhibitory
factor in the present system, it should be pos-
sible to replace normally inhibiting serum with
buffered human transferrin and produce the
same effect under the standard assay conditions.
Concentrations of transferrin up to 1500 ig%
were used and showed no effect on candidal
growth. Although the actual amount added to
the assay tube was 0.4 ml of a 1500 g% solu-
tion (600 pg% in the total volume), this may
be compared to 0.4 ml of a normal serum with
an approximate transferrin concentration of 250
/ig% (or 100 jxg% in the total volume). Schade
(1) has stated that biologically active purified
transfcrrin is exceedingly difficult to obtain and
inactivity might therefore, account for the lack
of inhibitory effect. This is unlikely in the pres-
ent study however, since lesser concentrations
of the same preparation added to non-inhibiting
serum from patients with either sickle cell ane-
mia or acute leukemia reversed the lack of in-
hibition. The inability of transferrin alone to
inhibit candidal growth might imply that the
presence of another and unknown factor in se-
rum is required for the demonstration of this
phenomenon. Less easily explained is the in-
ability of similar amounts of transferrin to re-
verse the lack of inhibition of cord serum. If the
degree of UIBC alone accounted for inhibition it
might be postulated that the UIBC of cord se-
rum was not only below a critical level to effect
inhibition but was lower than that from patients
with hemoglobinopatbics and blood dyscrasias.
However, consideration of the UIBCs in Figure
1 indicate that such is not the case. The reason
for this finding remains unexplained at present.
SUMMARY
The relationship of the transferrin-iron com-
plex to the in vitro inhibition of Candida albi-
cans by human serum was studied in a room
temperature system in wInch growth is by
blastospore formation alone. There was no in-
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hibition of candidal growth when transferrin
in phosphate buffer replaced serum in the assay.
However, when pooled transferrin was added to
certain of the non-inhibiting scra (leukemia,
hypoplastic anemia, sickle cell anemia, infant
three weeks of age) complete inhibition of can-
didal growth occurred. The addition of the same
amount of transferrin to cord scm (also non-
inhibiting) did not increase its inhibitory activ-
ity. The addition of ferrous or fcrric iron to
saturate the TJIBC reversed the effect of nor-
mally inhibiting serum but growth was not
further enhanced by larger amounts of iron.
A significant correlation was shown between
the anticandidal activity and the unsaturated
iron binding capacity of 59 sera. All of the
inhibitory scra had TIIBCs above 200 flg%;
21 of the 27 non-inhibitory sera had TJIBCs
below 200 flg%.
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